Resistance to mogamulizumab is associated with loss of CCR4 in Cutaneous T-cell Lymphoma. Beygi S, Duran GE, Fernandez-Pol S, Rook AH, et al. Blood 2022 Apr 18. pii: 484969. doi: 10.1182/blood.2021014468.

Read + Share

Amedeo Smart

Independent Medical Education

Beygi S, Duran GE, Fernandez-Pol S, Rook AH, et al. Resistance to mogamulizumab is associated with loss of CCR4 in Cutaneous T-cell Lymphoma. Blood 2022 Apr 18. pii: 484969. doi: 10.1182/blood.2021014468.
PMID: 35436328